Cairo-Mubasher: The Egyptian Exchange (EGX) said the listing committee approved last Tuesday to delist shares of DPKP Pharmaceutical on Thursday, in line with article No. 7 of the listing regulations.
Last August, the drug firm said it will delay its IPO until the conditions of local and global markets improve.
